Barclays
June 3, 2026
European Morning Research Summary
Market ReportEquitiesMacro Economic IndicatorsConsumer StaplesHealth Care
A comprehensive daily summary of Barclays' European equity research, covering ratings changes, sector updates in Consumer and Healthcare, and a macro-focused June equity strategy.
Key Takeaways
- 1.Barclays revised price targets and estimates for several European firms, notably increasing targets for Sodexo, Veolia, and CK Infrastructure while lowering them for Adecco and GB Group.
- 2.The June European Equity Strategy notes caution due to 'frothy' edges in AI and Semiconductors, but maintains a positive view on the 'solid core' of earnings and liquidity.
- 3.AstraZeneca received positive clinical data updates for camizestrant (SERENA-6), which may support FDA approval despite a previously negative ODAC vote.
Table of Contents
- Summary of Changes
- Industry Research
- Equity Strategy
- Publications Summary
- Consumer
- Financial Services
- Healthcare
- Industrials
- Internet & Media
- Power & Utilities
- Retail
- Analyst(s) Certification(s)
- Important Disclosures
Access the Full Report
Get unlimited access to institutional research reports with a 14-day free trial.
Authors
Emmanuel Cau, CFAAmos Fletcher, CFA
Securities
ADEN.SAZN.LCKI.LNESN.SVeolia
Themes
Post-Earnings Strategic ResetsShareholder Returns & BuybacksRegulatory and Political Risk in Utilities
Regions
EuropeUnited KingdomSwitzerlandFrance